19 May 2018
Come along to our free orthopaedic information event.
We welcome your views on our website and invite you to take part in a brief survey when you've finished your visit.
Your response will help us improve the site and the experience we offer to visitors.
Some of the principal treatments carried out by Dr Duncan McLaren at Spire include:
Availability - Murrayfield: Thursday 1pm-4pm.
I am a specialist in Genito-Urinary Oncology and run a large practice offering non-surgical treatment with radiotherapy and chemotherapy for Urological Cancer patients. I have a particular interest in prostate brachytherapy (seeds) and dose escalated hypo-fractionated radiotherapy. Edinburgh was the first Scottish Centre to offer prostate brachytherapy in 2001. State of the art volumetric arc based radiotherapy (VMAT) intensity modulated radiotherapy (IMRT) for prostate cancer is routinely available. In addition the prostate stereotactic ablative radiotherapy (SBRT) service will be up and running in 2017.
For patients with bladder cancer neo-adjuvant chemotherapy is routinely used before surgery or concurrent chemo-radiotherapy. I am a co-investigator on the UK RAIDER trial investigating dose escalated IMRT for bladder cancer in addition.
Chemotherapy and new targeted therapy drugs are an important area of disease management. I have extensive experience in the use of Taxotere chemotherapy Abiraterone, Enzalutamide and Alpharadin for example in prostate cancer and Sunitinib, Pazopanib and Axitinib for renal cancer. I ensure early access to newly licensed effective drugs and entry into clinical trials for new treatments as team leader for Urological cancer trials with in the SE of Scotland.
I also have a very exciting on-going collaboration with the University of Edinburgh Department of Electrical Engineering, Royal Dick Veterinary School and Edinburgh Cancer Research Centre to develop a micro chip system to provide real time measurements of tumour oxygen levels. In time I hope to implant this device directly into tumours within the prostate and individualise radiotherapy treatments by timing radiotherapy delivery with peak oxygen levels within the tumour. In addition I am co-investigator on a biomarker of radiation sensitivity project as part of a large European grant and ongoing research with oncology physics to identify tumours more accurately for targeting with radiotherapy via novel imaging processing techniques.
|Telephone||0131 316 2530|
|Private secretary||07514 232839|
|Private secretary firstname.lastname@example.org|
Royal College of Radiologists (London)
Royal College of Physicians (Edin)
Former member of National Cancer Research Network Clinical Trials (NCRN) group for Prostate Cancer and Bladder Cancer
British Urological Group
South East Scotland GU Cancer Group (SCAN)
UK and Ireland Brachytherapy Users Group
Chair of the Edinburgh Radiation Research Collaborative
Consultant Clinical Oncologist Edinburgh Cancer Centre
Honorary Senior Lecturer University of Edinburgh
Undergraduate training at St Mary's Hospital Medical School in London from 1983-1989. I also undertook an intercalated BSc in Clinical Science and gained First Class Honours. General Medical training at Queens University Hospital Nottingham. Specialist cancer training at Velindre Cancer Hospital Cardiff. Clinical Fellowship specialising in GU oncology at the British Columbia Cancer Agency, Vancouver.
Appointed as Consultant Clinical Oncologist and Honorary Clinical Senior Lecturer at the Edinburgh Cancer Centre in 1998. I am married with two children and a dog and stay in Edinburgh. I enjoy playing as much golf and supporting as much rugby as time allows.Back to top